sb 203580 has been researched along with 4-(2-aminoethyl)benzenesulfonylfluoride in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (4-(2-aminoethyl)benzenesulfonylfluoride) | Trials (4-(2-aminoethyl)benzenesulfonylfluoride) | Recent Studies (post-2010) (4-(2-aminoethyl)benzenesulfonylfluoride) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 247 | 1 | 79 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bucio, L; Escobar, Mdel C; Gómez-Quiroz, LE; Gutiérrez Ruiz, MC; Hernández, E; Souza, V | 1 |
1 other study(ies) available for sb 203580 and 4-(2-aminoethyl)benzenesulfonylfluoride
Article | Year |
---|---|
NADPH oxidase and ERK1/2 are involved in cadmium induced-STAT3 activation in HepG2 cells.
Topics: Allopurinol; Anthracenes; Blotting, Western; Cadmium; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; Liver; NADPH Oxidases; Onium Compounds; Phosphorylation; Potassium Cyanide; Pyridines; Signal Transduction; STAT3 Transcription Factor; Sulfones | 2009 |